Investor Frost Phillip Md Et Al
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Frost Phillip Md Et Al . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-26 13D/A FLNT / Fluent, Inc. 6,731,308 7,302,737
2025-06-11 13D/A NNUP / Nocopi Technologies, Inc. 1,250,000 1,467,782
2025-05-23 13D/A FLNT / Fluent, Inc. 4,912,926 6,731,308
2025-04-03 13D/A OPK / OPKO Health, Inc. 250,460,363 252,399,406
2025-04-02 13D/A FLNT / Fluent, Inc. 3,805,165 4,912,926
2025-02-11 13G/A DOUG / Douglas Elliman Inc. 7,191,066 7,650,618
2024-11-15 13D/A OPK / OPKO Health, Inc. 250,080,180 250,460,363
2024-10-15 13D/A VGR / Vector Group Ltd. 10,553,489 0
2024-10-01 13D/A VGR / Vector Group Ltd. 14,763,520 10,553,489
2024-08-29 13D/A OPK / OPKO Health, Inc. 244,703,683 250,080,180
2024-08-26 13D/A FLNT / Fluent, Inc. 3,738,498 3,805,165
2024-05-20 13D/A FLNT / Fluent, Inc. 18,884,874 3,738,498
2024-02-06 13G/A VERU / Veru Inc. 5,100,253 5,100,253
2024-01-24 13D/A OPK / OPKO Health, Inc. 244,703,683 244,703,683
2024-01-22 13D/A OPK / OPKO Health, Inc. 252,427,393 244,703,683
2023-09-28 13G/A VERU / Veru Inc. 5,000,253 5,100,253
2023-09-25 13D/A FLNT / Fluent, Inc. 18,784,874 18,884,874
2023-09-15 13D NNUP / Nocopi Technologies, Inc. 1,250,000
2023-04-19 13G/A COMS / COMSovereign Holding Corp. 4,561,607 45,618
2023-04-19 13G VERU / Veru Inc. 5,000,253
2023-04-14 13D NXPL / NextPlat Corp 3,428,571
2023-04-14 13D/A COCP / Cocrystal Pharma, Inc. 1,332,608
2023-02-21 13D/A OPK / OPKO Health, Inc. 240,592,152 252,427,393
2023-02-03 13G/A DOUG / Douglas Elliman Inc. 7,126,744 7,191,066
2023-02-03 13G/A PKBO / Peak Bio, Inc. 315,000
2022-08-19 13D/A OPK / OPKO Health, Inc. 229,723,463 240,592,152
2022-02-11 13G DOUG / Douglas Elliman Inc. 7,126,744
2021-06-10 13D/A COCP / Cocrystal Pharma, Inc. 100,269,114 3,726,306
2021-03-02 13D/A CDXC / ChromaDex Corporation 3,251,521 2,351,521
2021-03-02 13G COMS / COMSovereign Holding Corp. 4,561,607
2021-02-25 13G IGNYU / Ignyte Acquisition Corp - Units (1 Ord & 1/2 War) 450,000 450,000
2021-02-25 13G 45175H205 / Ignyte Acquisition Corp. 450,000
2020-12-23 13D/A RDVT / Red Violet, Inc. 2,504,648 6,666
2019-12-10 13D/A VGR / Vector Group Ltd. 19,536,686 14,763,520
2019-11-01 13D/A OPK / OPKO Health, Inc. 222,146,463 229,723,463
2019-10-18 13D/A ROX / Castle Brands, Inc. 54,236,285 0
2019-09-05 13D/A ROX / Castle Brands, Inc. 54,221,285 54,236,285
2019-04-24 13D/A NIMU / Non-Invasive Monitoring Systems, Inc. 54,703,450 54,690,325
2019-03-22 13D/A OPK / OPKO Health, Inc. 222,106,463 222,146,463
2019-03-20 13D/A OPK / OPKO Health, Inc. 220,841,463 222,106,463
2019-02-14 13D/A ROX / Castle Brands, Inc. 54,146,285 54,221,285
2019-02-14 13D/A FLNT / Fluent, Inc. 18,784,874
2019-02-14 13D/A RDVT / Red Violet, Inc. 2,504,648 2,504,648
2019-02-14 13D/A VGR / Vector Group Ltd. 195,366,861 19,536,686
2019-02-14 13D/A CDXC / ChromaDex Corporation 3,340,410 3,251,521
2019-01-23 13G/A PTE / PolarityTE Inc 0
2019-01-11 13D/A NIMU / Non-Invasive Monitoring Systems, Inc. 54,703,450
2018-12-27 13D/A LTSK / Osaic Financial Services, Inc. - Corporate Bond/Note 7,024,630
2018-12-11 13D/A VGR / Vector Group Ltd. 19,536,686
2018-11-20 13D/A OPK / OPKO Health, Inc. 220,841,463
2018-04-06 13D RDVT / Red Violet, Inc. 2,504,648
2018-04-06 13D/A 19241Q101 / Cogint, Inc. 15,751,541 18,784,874
2018-03-16 13D/A ROX / Castle Brands, Inc. 53,913,662 54,146,285
2018-02-06 13G/A PTE / PolarityTE Inc 480,785
2018-01-31 13G/A MBVX / MabVax Therapeutics Holdings, Inc. 1,059,157 1,059,157
2018-01-30 13G/A MBVX / MabVax Therapeutics Holdings, Inc. 422,334 1,059,157
2017-12-29 13D/A CDXC / ChromaDex Corporation 3,493,410 3,340,410
2017-12-27 13D/A ELOX / Eloxx Pharmaceuticals, Inc. 593,944
2017-12-27 13D/A ELOX / Eloxx Pharmaceuticals, Inc. 1,746,111 593,944
2017-12-22 13D/A 19241Q101 / Cogint, Inc. 15,751,541
2017-08-17 13D/A CDXC / ChromaDex Corporation 3,558,410 3,493,410
2017-02-09 13D/A ELOX / Eloxx Pharmaceuticals, Inc. 2,110,984 1,746,111
2017-02-08 13G/A PTE / PolarityTE Inc 444,928
2017-02-03 13G/A MBVX / MabVax Therapeutics Holdings, Inc. 1,453,667 422,334
2016-12-29 13D/A BCDA / BioCardia, Inc. 149,734,604 130,503,835
2016-12-29 13D/A BCDA / BioCardia, Inc. 149,734,604 130,503,835
2016-12-28 13D/A 19241Q101 / Cogint, Inc. 15,704,874
2016-12-28 13D/A IDI / IDI, Inc. 15,639,773 15,704,874
2016-11-10 13D/A BCDA / BioCardia, Inc. 149,734,604
2016-11-10 13D/A BCDA / BioCardia, Inc. 149,734,604 149,734,604
2016-09-14 13D/A CDXC / ChromaDex Corporation 3,972,910 3,558,410
2016-07-27 13D/A CDXC / ChromaDex Corporation 3,972,910
2016-07-21 13D/A IDI / IDI, Inc. 15,607,973 15,639,773
2016-05-18 13D/A IDI / IDI, Inc. 13,417,973 15,607,973
2016-05-17 13D/A BCDA / BioCardia, Inc. 149,734,604
2016-03-29 13D/A IDI / IDI, Inc. 12,487,865 13,417,973
2016-03-02 13D/A ROX / Castle Brands, Inc. 53,913,662
2016-02-08 13G/A MBVX / MabVax Therapeutics Holdings, Inc. 1,333,333 1,453,667
2016-01-28 13D/A ASXC / Asensus Surgical, Inc. 4,380,469
2016-01-20 13D/A IDI / IDI, Inc. 4,804,588 12,487,865
2015-10-16 13D/A ELOX / Eloxx Pharmaceuticals, Inc. 2,110,984
2015-04-10 13G MBVX / MabVax Therapeutics Holdings, Inc. 1,333,333
2015-04-06 13D/A IDI / IDI, Inc. 4,804,588
2015-02-13 13G/A MSLP / MusclePharm Corp 456,372
2015-02-04 13D/A VGR / Vector Group Ltd. 17,883,559
2014-12-31 13D/A PPRTF / Peiport Holdings Ltd 18,340,640
2014-12-29 13D/A ELOX / Eloxx Pharmaceuticals, Inc. 1,576,488
2014-11-17 13D/A VGR / Vector Group Ltd. 17,883,559
2014-08-21 13D COCP / Cocrystal Pharma, Inc. 100,269,114
2014-08-15 13D/A ROX / Castle Brands, Inc. 53,873,662
2014-06-20 13D/A ELOX / Eloxx Pharmaceuticals, Inc. 2,108,775
2014-05-29 13D ELOX / Eloxx Pharmaceuticals, Inc. 1,563,816
2014-04-22 13G MSLP / MusclePharm Corp 738,314
2014-04-03 13D/A VGR / Vector Group Ltd.
2014-03-14 13D/A ROX / Castle Brands, Inc. 53,873,662
2014-02-14 13D/A IDI / IDI, Inc. 10,666,790
2014-02-04 13D/A LTSK / Osaic Financial Services, Inc. - Corporate Bond/Note 70,902,130
2014-01-03 13D/A CDXC / ChromaDex Corporation 15,252,937
2013-12-19 13D/A ASXC / Asensus Surgical, Inc. 21,802,346
2013-09-17 13D/A ASXC / Asensus Surgical, Inc. 14,382,346
2013-09-09 13D/A PBTH / Prolor Biotech, Inc. 0
2013-07-12 13D/A IDI / IDI, Inc. 10,666,790
2013-03-21 13D/A OPK / OPKO Health, Inc. 20,286,704
2013-01-17 13D/A IDI / IDI, Inc. 10,334,790
2012-08-30 13D PPRTF / Peiport Holdings Ltd 36,045,166
2012-08-23 13D/A IDI / IDI, Inc. 10,470,024
2012-07-20 13D/A IDI / IDI, Inc. 7,827,559
2012-07-12 13D/A CDXC / ChromaDex Corporation 15,252,937
2012-05-16 13D/A PBTH / Prolor Biotech, Inc. 12,596,601
2012-03-07 13D/A NIMU / Non-Invasive Monitoring Systems, Inc. 19,348,125